Bristol-Myers Squibb

YTD

ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.

CEO

Christopher S. Boerner

CEOChristopher S. Boerner

Employees

32,500

Employees32,500

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1933

Founded1933

Employees

32,500

Employees32,500

BMY Key Statistics

Market cap

136.51B

Market cap136.51B

Price-Earnings ratio

14.67

Price-Earnings ratio14.67

Dividend yield

3.77%

Dividend yield3.77%

Average volume

8.48M

Average volume8.48M

High today

$67.20

High today$67.20

Low today

$65.91

Low today$65.91

Open price

$66.20

Open price$66.20

Volume

12.68M

Volume12.68M

52 Week high

$68.64

52 Week high$68.64

52 Week low

$42.52

52 Week low$42.52

Stock Snapshot

Bristol-Myers Squibb(BMY) stock is priced at $66.95, giving the company a market capitalization of 136.51B. It carries a P/E multiple of 14.67 and pays a dividend yield of 3.77%.

On 2026-09-01, Bristol-Myers Squibb(BMY) stock moved within a range of $65.91 to $67.20. With shares now at $66.95, the stock is trading +1.6% above its intraday low and -0.4% below the session's peak.

Trading volume for Bristol-Myers Squibb(BMY) stock has reached 12.68M, versus its average volume of 8.48M.

The stock's 52-week range extends from a low of $42.52 to a high of $68.64.

BMY News

24/7 Wall St. 12h

Investing This Popular Healthcare ETF Is Diluting Your Dividend Income XLV bundles the entire healthcare sector into one tidy package, but its cap-weighted stru...

Simply Wall St 2d

Bristol Myers Squibb Unveils Five Year Camzyos Data At ESC Congress

Bristol-Myers Squibb (NYSE:BMY) presented new long term and real world data for Camzyos in obstructive hypertrophic cardiomyopathy at the European Society of Ca...

TipRanks 5d

Top Bristol-Myers Squibb Executive Makes Notable Move With Recent Stock Sale

New insider activity at Bristol-Myers Squibb ( (BMY) ) has taken place on August 26, 2026. Phil M. Holzer, Senior Vice President and Controller at Bristol-Myers...

Analyst ratings

58%

of 31 ratings

Buy

35.5%

Hold

58.1%

Sell

6.5%

More BMY News

Simply Wall St 6d

Bristol Myers Squibb Faces New Patent Challenge Over Heart Drug Rights

Cytokinetics has filed a legal complaint against Bristol-Myers Squibb (NYSE:BMY) and MyoKardia over patents linked to the heart drug MYQORZO, also known as afic...

TipRanks 6d

Bristol Myers Squibb Stock Looks Healthier After Ditching Blood Cancer Partner

Shares in biopharmaceutical stock Bristol Myers Squibb (BMY) remained healthy today despite scrapping its partnership with California-based blood cancer startup...

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.